The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor era
Tyrosine kinase inhibitors have changed the management and outcomes of chronic myeloid leukemia patients. Quantitative polymerase chain reaction is used to monitor molecular responses to tyrosine kinase inhibitors. Molecular monitoring represents the most sensitive tool to judge chronic myeloid leukemia disease course and allows early detection of relapse. Evidence of achieving molecular response is important for several reasons: 1. early molecular response is associated with major molecular response rates at 18-24 months; 2. patients achieving major molecular response are less likely to lose their complete cytogenetic response; 3. a durable, stable major molecular response is associated with increased progression-free survival. However, standardization of molecular techniques is still challenging.
Main Authors: | Renault,Ilana Zalcberg, Scholl,Vanesa, Hassan,Rocio, Capelleti,Paola, Lima,Marcos de, Cortes,Jorge |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
2011
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000600015 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice
by: Boquimpani,Carla, et al.
Published: (2022) -
Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
by: Almeida,Maria Helena de, et al.
Published: (2014) -
Successful treatment of chronic myeloid leukemia with tyrosine kinase inhibitors goes beyond access to drugs
by: Conchon,Monika
Published: (2013) -
Imatinib resistance: a review of alternative inhibitors in chronic myeloid leukemia
by: Bitencourt,Roberta, et al.
Published: (2011) -
Serum concentrations of nitrite and malondialdehyde as markers of oxidative stress in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
by: Petrola,Maria Juracy, et al.
Published: (2012)